Breaking News

Kadans Expands Relationship with Oxford Biomedica

The Kadans portfolio now comprises of over 65 buildings and numerous projects under development in six European countries.

Kadans Science, a company involved in investing in the development of ecosystems, will add Harrow House in Oxford, UK to its Pan-European portfolio. The asset will be acquired from Oxford Biomedica in a sale and lease back transaction. Harrow House is a purpose-built manufacturing facility which will be leased back, in its entirety, to Oxford Biomedica. Oxford Biomedica is an innovation-led viral vector contract development and manufacturing organization (CDMO), providing development and manufac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters